<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-AR2O08P1</identifier><date>2024</date><creator>Hotujec, Simona</creator><creator>Krajc, Mateja</creator><creator>Novaković, Srdjan</creator><creator>Stegel, Vida</creator><creator>Zavrl, Nina</creator><relation>documents/doc/A/URN_NBN_SI_doc-AR2O08P1_001.pdf</relation><relation>documents/doc/A/URN_NBN_SI_doc-AR2O08P1_001.txt</relation><format format_type="issue">2</format><format format_type="volume">28</format><format format_type="type">article</format><format format_type="extent">str. 6-14</format><identifier identifier_type="DOI">10.25670/oi2024-012on</identifier><identifier identifier_type="ISSN">1408-1741</identifier><identifier identifier_type="COBISSID_HOST">223995395</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-AR2O08P1</identifier><language>slv</language><publisher>Onkološki inštitut Ljubljana</publisher><source>Onkologija (Ljubljana)</source><rights>BY</rights><subject language_type_id="slv">genetsko testiranje</subject><subject language_type_id="slv">patogene različice</subject><subject language_type_id="slv">zaviralci PARP</subject><title>Analiza obravnav na Oddelku za onkološko klinično genetiko po posamezni lokaciji raka in pomen genetskih izvidov pri načrtovanju zdravljenja</title><title>Analysis of assessments at the Department of Clinical Cancer Genetics by cancer site and the importance of genetic findings in treatment planning</title></Record>